Zusammenfassung
BackgroundSymptoms have been identified as a core outcome domain for atopic eczema (AE) trials. Various instruments exist to measure symptoms in AE, but they vary in quality and there is a lack of standardization between clinical trials. Our objective was to systematically evaluate the quality of the evidence on the measurement properties of AE symptom instruments, thereby informing consensus ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric